Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial
Gomaa et al., Inflammopharmacology, doi:10.1007/s10787-022-00939-7
https://c19early.org/gomaa.html